Published in Arch Int Pharmacodyn Ther on August 01, 1979
Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Mayo Clin Proc (1999) 1.96
Effects of a prostaglandin E1 derivative, SC-29333, and aspirin on gastric ionic fluxes and potential difference in dogs. J Pharmacol Exp Ther (1979) 1.08
Loperamide binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther (1976) 1.06
Chemistry and synthetic development of misoprostol. Dig Dis Sci (1985) 1.05
SC-29333: a potent inhibitor of canin gastric secretion. Am J Dig Dis (1976) 1.04
Effects of E prostaglandins on canine gastric potential difference. Am J Dig Dis (1978) 1.03
Effect of SC-29333, an inhibitor of gastric secretion, on canine gastric mucosal blood flow and serum gastrin levels. Arch Int Pharmacodyn Ther (1978) 0.87
The pharmacology of SC-27166: a novel antidiarrheal agent. J Pharmacol Exp Ther (1977) 0.87
Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study. Dig Dis Sci (1985) 0.87
Comparative gastric antisecretory and antiulcer effects of prostaglandin E1 and its methyl ester in animals. Prostaglandins (1975) 0.86
3,3-Diphenyl-3-(2-alkyl-1,3,4-oxadiazol-5-yl)propylcycloalkylamines, a novel series of antidiarrheal agents. J Med Chem (1976) 0.86
Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1. Dig Dis Sci (1985) 0.85
Inhibition of intestinal secretion in the dog: a new approach for the management of diarrheal states. J Pharmacol Exp Ther (1981) 0.85
Comparative cytoprotective effects against alcohol insult. Misoprostol versus cimetidine. Dig Dis Sci (1986) 0.84
Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates. Am J Pathol (1995) 0.83
Systemic treatment with epidermal growth factor in pigs induces ductal proliferations in the pancreas. Gastroenterology (1997) 0.82
Idiopathic esophageal ulceration in acquired immunodeficiency syndrome: successful treatment with misoprostol and viscous lidocaine. Am J Gastroenterol (1998) 0.82
Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man. Dig Dis Sci (1988) 0.81
Is peptic ulcer a prostaglandin deficiency disease? Hum Pathol (1986) 0.81
Effects of E prostaglandins, diphenoxylate and morphine on intestinal motility in vivo. Eur J Pharmacol (1975) 0.80
Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas. Br J Cancer (1991) 0.80
Impedance planimetric characterization of the distal oesophagus in the Goettingen minipig. J Biomech (1996) 0.80
Misoprostol but not antacid prevents endotoxin-induced gastric mucosal injury: role of tumor necrosis factor-alpha. Dig Dis Sci (1991) 0.79
Gastrointestinal cytoprotective effects of misoprostol. Clinical efficacy overview. Dig Dis Sci (1985) 0.78
Systemic treatment with recombinant human epidermal growth factor accelerates healing of sclerotherapy-induced esophageal ulcers and prevents esophageal stricture formations in pigs. Dig Dis Sci (1994) 0.78
Tissue distribution of 131I-labelled epidermal growth factor in the pig visualized by dynamic scintigraphy. J Endocrinol (1995) 0.78
Biomechanical properties of the oesophagus damaged by endoscopic sclerotherapy. An impedance planimetric study in minipigs. Scand J Gastroenterol (1994) 0.78
Effect of misoprostol, an antiulcer prostaglandin, on serum gastrin in patients with duodenal ulcer. Dig Dis Sci (1986) 0.77
Refractory peptic ulcers. J Assoc Acad Minor Phys (1992) 0.77
Chronic systemic treatment with epidermal growth factor induces hypergastrinaemia in Goettingen minipigs. Scand J Gastroenterol (1995) 0.77
Gastrointestinal toxicity of over-the-counter analgesics. Am J Gastroenterol (1998) 0.77
Gastric antisecretory actions of (15S)-15-methyl prostaglandin E2 methyl ester and natural prostaglandin E2 in rhesus monkeys. Prostaglandins (1976) 0.77
Misoprostol prevents damage to the gastric mucosa by stabilizing the mast cells. Prostaglandins (1987) 0.77
Chronic treatment with epidermal growth factor causes esophageal epithelial hyperplasia in pigs and rats. Dig Dis Sci (1995) 0.76
Cytoprotection by a synthetic prostaglandin against ethanol-induced gastric mucosal damage. A double-blind endoscopic study in human subjects. Gastrointest Endosc (1986) 0.76
Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis. Ann Rheum Dis (1993) 0.76
Antidiarrheal and central nervous system activities of SC-27166 (2-[3 - 5 - methyl - 1, 3, 4 - oxadiazol - 2 - yl) - 3, 3 - diphenylpropyl] - 2 - azabicyclo [2.2.2]octane), a new antidiarrheal agent, resulting from binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther (1977) 0.76
Epidermal growth factor attenuates the sclerotherapy-induced biomechanical properties of the oesophagus. An experimental study in minipigs. Scand J Gastroenterol (1995) 0.76
Synthesis and gastric antisecretory properties of 15-deoxy-16-hydroxyprostaglandin E analogues. J Med Chem (1977) 0.75
Misoprostol attenuates aspirin-induced changes in potential difference and associated damage in canine gastric mucosa. Clin Invest Med (1987) 0.75
Omega-3 fatty acids and bowel cancer. Gastroenterology (1993) 0.75
Prostaglandins, NSAIDS, and GI mucosal integrity: can we identify patients at risk of NSAID-induced gastric injury? Am J Gastroenterol (1996) 0.75
Update on acid-peptic disorders. J Assoc Acad Minor Phys (1992) 0.75
Ureteric growth in a Goettingen minipig induced by epidermal growth factor. A case report. Scand J Urol Nephrol Suppl (1995) 0.75
Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs. J Assoc Acad Minor Phys (1992) 0.75
Idiopathic esophageal ulceration in patients infected with human immunodeficiency virus. J Assoc Acad Minor Phys (1996) 0.75
Synthesis and gastric antisecretory properties of 4,5-unsaturated derivatives of 15-deoxy-16-hydroxy-16-methylprostaglandin E1. J Med Chem (1983) 0.75
Gastric antiulcer and antisecretory effects of carbenoxolone, aldosterone and desoxycorticosterone in rats. Arch Int Pharmacodyn Ther (1979) 0.75
Future treatment of peptic ulcer: is there room for anti-infective drugs? J Physiol Pharmacol (1993) 0.75
Design and hardware selection of a microcomputer based system for the recording of animal observation data. Drug Inf J (1978) 0.75
Synthesis and gastric antisecretory properties of alpha chain diene derivatives of misoprostol. J Med Chem (1986) 0.75
Synergistic actions of propantheline bromide with cimetidine and thiopropazate hydrochloride in the prevention of stress ulcer formation in rats. J Pharmacol Exp Ther (1979) 0.75
Synthesis and biological evaluation of omega-homologues of prostaglandin E1. J Med Chem (1976) 0.75
Chronic administration of epidermal growth factor to pigs induces growth, especially of the urinary tract with accumulation of epithelial glycoconjugates. Lab Invest (1995) 0.75
Influence of the position of the side chain hydroxy group on the gastric antisecretory and antiulcer actions of E1 prostaglandin analogs. Prostaglandins (1975) 0.75
Highlights of the 14th Annual Scientific Meeting of the Association for Academic Minority Physicians, 2000. J Assoc Acad Minor Phys (2001) 0.75
Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage. J Rheumatol Suppl (1990) 0.75
Effect of oral and intravenous propantheline bromide on pentagastrin-stimulated canine gastric secretion. Arch Int Pharmacodyn Ther (1978) 0.75
Antiulcer drugs and gastric mucosal integrity. Effects of misoprostol, 16,16-dimethyl PGE2, and cimetidine on hemodynamics and metabolic rate in canine gastric mucosa. Dig Dis Sci (1992) 0.75
Effects of 7-oxa-13-prostynoic acid (7-OPyA) and prostaglandin E1 methyl ester on canine gastric secretion. Prostaglandins (1977) 0.75
Is cytoprotection by misoprostol against ethanol-induced gastric mucosal injury in man mediated by somatostatin? Prostaglandins (1987) 0.75
Canine gastrointestinal motility effects of prostaglandin F2 alpha in vivo. Arch Int Pharmacodyn Ther (1979) 0.75
Gastric antisecretory effects of propantheline bromide and metiamide in rhesus monkeys. Arch Int Pharmacodyn Ther (1978) 0.75
Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury. Int J Clin Pharmacol Res (1989) 0.75
Novel, low cost approach to digitizing tablet hardness values. J Pharm Sci (1975) 0.75
Chronic systemic treatment with epidermal growth factor induces smooth muscle cell hyperplasia and hypertrophy in the urinary tract of mature Goettingen minipigs. Br J Urol (1997) 0.75
The effect of epidermal growth factor on circulating levels of IGF and IGF-binding proteins in adult Goettingen minipigs. J Endocrinol (1996) 0.75
Nonsteroidal anti-inflammatory drugs and acute upper gastrointestinal bleeding: a prospective study. J Assoc Acad Minor Phys (1991) 0.75
Systemic treatment with epidermal growth factor induces anaemia in Goettingen minipigs. Clin Sci (Lond) (1995) 0.75
Instrumentation of a tablet breaking-strength tester. J Pharm Sci (1984) 0.75
Gastric antisecretory effects of E prostaglandins in Rhesus monkeys. Am J Dig Dis (1976) 0.75
Preventive effects of recombinant human epidermal growth factor on the oesophageal epithelium in pigs subjected to sclerotherapy. Eur J Gastroenterol Hepatol (1995) 0.75
Effects of tolcapone, a catechol-O-methyltransferase inhibitor, and Sinemet on intestinal electrolyte and fluid transport in conscious dogs. Dig Dis Sci (1998) 0.75